SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950103-11-002059
Filing Date
2011-05-26
Accepted
2011-05-26 16:47:25
Documents
1
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS AND CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS, LLCWARBURG PINCUS X LLCWARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A dp22819_sc13da4.htm SC 13D/A 270593
  Complete submission text file 0000950103-11-002059.txt   272483
Mailing Address NO.14 EAST HUSHAN ROAD TAI'AN CITY, SHANDONG F4 271000
Business Address NO.14 EAST HUSHAN ROAD TAI'AN CITY, SHANDONG F4 271000 86-538-620-3897
China Biologic Products, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 11874653
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017
Business Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
Warburg Pincus Private Equity X, L.P. (Filed by) CIK: 0001414565 (see all company filings)

IRS No.: 200849130
Type: SC 13D/A